Prostaglandin E2 stimulates the growth of human blood CD34+ progenitors

Prostaglandins and Other Lipid Mediators

Volumn 55, Issue 2-3, 1998, Pages 179-186

  Dupuis, Fabienne ^a   Gachard, Nathalie ^a   Allegraud, Annie ^a   Praloran, Vincent ^a   Denizot, Yves ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

BFU E; CD34+ cells; CFU GM; PGE2

Indexed keywords

CD34 ANTIGEN; PROSTAGLANDIN E2;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; COLONY FORMING UNIT GM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; GRANULOPOIESIS; HUMAN; HUMAN CELL;

EID: 0032001397     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(98)00019-7     Document Type: Article

References (20)

1. Mayani H., Guilbert L.J., Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur. J. Haematol. 49:1992;225.
2. Rougier F., Dupuis F., Denizot Y. Human bone marrow fibroblasts - an overview of their characterization, proliferation and inflammatory mediator production. Hematol. Cell Ther. 38:1996;241.
3. + positive haemopoietic cells Biology and clinical applications . Blood Rev. 8:1994;113.
4. Krause D.S., Fackler M.J., Civin C.I., May W.S. CD34 Structure, biology, and clinical utility . Blood. 87:1996;1.
5. Bender J.G., Unverzagt K.L., Walker D.E., et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood. 77:1991;2591.
6. Dupuis F., Desplat V., Praloran V., Denizot Y. Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. J. Lipid Mediators Cell Signalling. 16:1997;117.
7. 2 and cAMP with murine and human erythroid precursors. Blood. 56:1980;74.
8. Taetle R., Guittard J.P., Mendelsohn J.M. Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglandin E in chronic myeloproliferative disorders. Exp. Hematol. 8:1980;1190.
9. Taetle R., Koessler A. Effects of cyclic nucleotides and prostaglandins on normal and abnormal human myeloid progenitor proliferation. Cancer Res. 40:1980;1223.
10. Aglietta M., Piacibello W., Gavosto F. Insensitivity of chronic myeloid leukemia cells to inhibition of growth by prostaglandin E. Cancer Res. 40:1980;2507.
11. Kaashoek J.G.J., Mout R., Falkenburg J.H.F., Willemze R., Fibbe W.E., Landegent J.E. Cytokine production by the bladder carcinoma cell line 5637 Rapid analysis of mRNA expression levels using a cDNA-PCR procedure . Lymphokine Cytokine Res. 10:1990;231.
12. + subpopulations in response to growth factors. Blood. 82:1993;3307.
13. De Wynter E.A., Coutinho L.H., Pei X., et al. Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems. Stem Cells. 13:1995;524.
14. + hematopoietic progenitor cells. Stem Cells. 14:1996;430.
15. + human hemopoietic progenitor cells of the bone marrow differ from those of the peripheral blood An immunocytochemical and morphometric study . Acta Haematol. 93:1995;83.
16. Snyder D.S., Desforges J.F. Lipoxygenase metabolites of arachidonic acid modulate hematopoiesis. Blood. 67:1996;1675.
17. Miller A.M., Weiner R.S., Ziboh V.A. Evidence for the role of leukotrienes C4 and D4 as essential intermediates in CSF-stimulated human myeloid colony formation. Exp. Hematol. 14:1986;760.
18. Nathan N., Denizot Y., Feiss P. Eicosanoid and cytokine levels in plasma of patients during mesenteric infarction. Med. Inflamm. 6:1997;75.
19. 2 in patients with diabetic ketoacidosis and in normal fasting subjects. Diabetes. 35:1986;1004.
20. Dzau V.J., Swartz S.L. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease. Am. J. Cardiol. 60:1987;1101.